Ask an expert
Buy with confidence.
Contact our experts today.
Buy with confidence.
Contact our experts today.
Description
The WELLLIFE™ COVID-19 / Influenza A&B Test is a cutting-edge point-of-care diagnostic tool designed for rapid and accurate detection of COVID-19 and influenza A and B viruses. Ideal for use in clinical settings, this test provides reliable results within 10 minutes, allowing healthcare providers to make swift and informed decisions. With an extended detection window and built-in quality assurance features, it is a vital resource for managing viral infections effectively.
Features
- Cost-effective: Efficiently screen for three types of antigens with one test kit.
- Rapid Results: Obtain test results within 10 minutes, aiding in immediate decision-making for patient care.
- Quality Assurance: Built-in controls ensure reliable performance and clinical accuracy.
- Extended Detection Window: Detect antigens up to five days after symptom onset.
- Wide Storage Temperature: Easy storage between 36°F-86°F (2°C-30°C) for flexible inventory management.
Product Specifications
| Items Per Box: | 25 |
|---|---|
| Specimen Type: | Nasal Swab |
| Result Time: | 10 Minutes |
| SARS-COV-2 Positive Percent Agreement (PPA): | 87.5% |
| Influenza A Positive Percent Agreement (PPA): | 85.9% |
|---|---|
| Influenza B Positive Percent Agreement (PPA): | 86.8% |
| Negative Percent Agreement (NPA): | 99.7% |
See any errors on this page? Let us know
Compare Similar Items
Comparison Chart
Price:
Manufacturer:
Customer Rating:
Staff Favorite
Sale
Frequently Asked Questions (FAQs)
The test can be stored between 36°F-86°F (2°C-30°C), making it convenient for various healthcare settings.
Results are available in just 10 minutes, allowing for immediate testing and treatment decisions during the same office visit.
Yes, this product has been authorized by the FDA under Emergency Use Authorization (EUA) for the detection of SARS-CoV-2, influenza A, and influenza B antigens.
The test shows high Positive Percent Agreement (PPA) and Negative Percent Agreement (NPA) percentages, ensuring reliable diagnostic accuracy.